We are live on ! Find out more
BFM

Boston Financial Management Portfolio holdings

AUM $3.31B
1-Year Est. Return 19.4%
This Fund
S&P 500
This Quarter Est. Return
+7.2%
1 Year Est. Return
+19.4%
3 Year Est. Return
+30.07%
5 Year Est. Return
+107.8%
10 Year Est. Return
+274.5%
AUM
$1.73B
AUM Growth
+$85.6M
Cap. Flow
-$18.4M
Cap. Flow %
-1.06%
Top 10 Hldgs %
26.65%
Holding
272
New
9
Increased
43
Reduced
148
Closed
14

Top Sells

Rank Stock Value
1
CVX icon
Chevron
CVX
+$17.9M
2
OPLN
Openlane
OPLN
+$16.9M
3
UNH icon
UnitedHealth
UNH
+$11.1M
4
NVO
Novo Nordisk
NVO
+$8.86M
5
PEP icon
PepsiCo
PEP
+$8.78M

Sector Composition

Rank Sector Weight
1 Technology 17.39%
2 Healthcare 13.53%
3 Industrials 13.16%
4 Financials 12.62%
5 Consumer Discretionary 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BEN icon
226
Franklin Resources
BEN
$18B
-6,378
Closed -$211K
DD icon
227
DuPont de Nemours
DD
$18.8B
-3,433
Closed -$464K
GOOS
228
Canada Goose Holdings
GOOS
$866M
-4,695
Closed -$225K
SLB icon
229
SLB Ltd
SLB
$74.8B
-5,145
Closed -$224K
APC
230
DELISTED
Anadarko Petroleum
APC
-10,826
Closed -$492K

Similar funds

Boston Financial Management's Q2 2019 Portfolio in Review

As of Q2 2019, Boston Financial Management held 272 positions worth $1.73B, up 5.2% from $1.64B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Boston Financial Management's Q2 2019 filing shows 9 new, 43 increased, 148 reduced and 14 closed positions. Its largest new stake was IAA, Inc. Common Stock: 482,836 shares worth $18.7M. The largest sale was Chevron, an estimated $17.9M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Industrials.

  • Boston Financial Management's largest Q2 2019 buy was IAA, Inc. Common Stock: 482,836 shares worth $18.7M.
  • Boston Financial Management added most to Goldman Sachs ActiveBeta International Equity ETF in Q2 2019, an estimated $13.4M increase.
  • Boston Financial Management's biggest Q2 2019 reduction was Chevron, cutting an estimated $17.9M.
  • Boston Financial Management fully exited AstraZeneca in Q2 2019, selling an estimated $3.33M.
  • Boston Financial Management's ten largest holdings make up 27% of its $1.73B portfolio in Q2 2019.
  • Boston Financial Management opened 9 new positions and closed 14 in Q2 2019.
  • Boston Financial Management's portfolio value rose 5.2% quarter-over-quarter to $1.73B.

Based on Boston Financial Management's 13F filing for Q2 2019, filed 24 Jul 2019.